October 2021 Game-Changer: Hopefully the European Union will approve 3-5 additional Cv19 Treatments

If we acknowledge the available treatments, then we would not have digital passports, mandatory injections, masks and lockdowns. Is hope on the horizon?

We don’t need new treatments for Cv19, but we do need to acknowledge the treatments with proven safety and effectiveness.

According to the press release “COVID-19 Therapeutics Strategy: Commission identifies five promising candidate therapeutics” dated 29 June 2021 and still available at the time of this writing on 26 September 2021, the European Union expects to begin authorization of 3-5 new drug therapeutics for Cv19. The website states:

“The EU Strategy on COVID-19 Therapeutics aims to build a broad portfolio of COVID-19 therapeutics with the goal of having three new therapeutics available by October 2021 and possibly two more by the end of the year.”

“The five products are in an advanced stage of development and have a high potential to be among the three new COVID-19 therapeutics to receive authorisation by October 2021, the target set under the Strategy, provided the final data demonstrate their safety, quality and efficacy.”

Not surpisingly, the drugs being considered are all high-cost high-profit pharmaceutical drugs:

1. baricitinib from Eli Lilly

2. combination of bamlanivimab and etesevimab from Eli Lilly

3. combination of casirivimab and imdevimab from Regeneron Pharmaceuticals, Inc. and F. Hoffman-La Roche, Ltd

4. regdanvimab from Celltrion

5. sotrovimab from GlaxoSmithKline and Vir Biotechnology

Of course, they make no mention of diet or nutrition, despite the amazingly robust data supporting nutritional interventions generally and vitamin D specifically, as I reviewed previously.

DEEP DIVE RESEARCH ANALYSIS and COMMENTARY: Vitamin D treatment of severe hospitalized Cv19 in Journal of Clinical Endocrinology and Metabolism 2021 Jun

For more details see the Antiviral Nutrition Course and/or the summary video provided here below:

Any therapeutic approval would be a step forward for humanity:

1. If we acknowledge the available treatments, then we would not have digital passports, mandatory injections, masks and lockdowns.

Unless none of this is about public health and it is all about social hegemony:

2. The data supporting use of nonvaccine interventions such as vitamin D and the off-label use of specific drugs is more than sufficient to gain acceptance for approval/authorization in order to help people prevent and treat the disease and also to regain normal life/lifestyle.

DEEP DIVE RESEARCH ANALYSIS and COMMENTARY: Vitamin D treatment of severe hospitalized Cv19 in Journal of Clinical Endocrinology and Metabolism 2021 Jun

Antiviral Nutrition VIDEO: Benefits of the amino acid (acetyl)Cysteine, NAC

RESEARCH UPDATE: Vitamin D Levels in COVID-19 Outpatients, Clinical Effect of Supplementation (J Clin Med 2021 May)

Research Proves that Vitamin D is Safe and Beneficial against Many Types of Human Papilloma Virus Infections

Selenium promotes Antiviral Immunity, reduces Viral Mutation and Viral Replication: Excerpt from DrV's Clinical Protocol

Citation: https://ec.europa.eu/commission/presscorner/detail/en/ip_21_3299